175 related articles for article (PubMed ID: 29716631)
1. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
[TBL] [Abstract][Full Text] [Related]
2. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
3. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
[TBL] [Abstract][Full Text] [Related]
4. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
5. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
Malfettone A; Silvestris N; Paradiso A; Mattioli E; Simone G; Mangia A
Exp Mol Pathol; 2012 Jun; 92(3):296-303. PubMed ID: 22440733
[TBL] [Abstract][Full Text] [Related]
7. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
Gu Y; Yu H; Hao C; Martin TA; Hargest R; He J; Cheng S; Jiang WG
Oncotarget; 2017 Jan; 8(5):7753-7765. PubMed ID: 27999191
[TBL] [Abstract][Full Text] [Related]
8. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
9. NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
Mangia A; Scarpi E; Partipilo G; Schirosi L; Opinto G; Giotta F; Simone G
Oncotarget; 2017 Sep; 8(39):65730-65742. PubMed ID: 29029467
[TBL] [Abstract][Full Text] [Related]
10. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
11. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
12. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
13. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
14. Immunoprofile from tissue microarrays to stratify familial breast cancer patients.
Schirosi L; De Summa S; Tommasi S; Paradiso A; Sambiasi D; Popescu O; Simone G; Mangia A
Oncotarget; 2015 Sep; 6(29):27865-79. PubMed ID: 26312763
[TBL] [Abstract][Full Text] [Related]
15. Biological role of NHERF1 protein expression in breast cancer.
Mangia A; Chiriatti A; Bellizzi A; Malfettone A; Stea B; Zito FA; Reshkin SJ; Simone G; Paradiso A
Histopathology; 2009 Nov; 55(5):600-8. PubMed ID: 19912366
[TBL] [Abstract][Full Text] [Related]
16. Involvement of nuclear NHERF1 in colorectal cancer progression.
Mangia A; Saponaro C; Malfettone A; Bisceglie D; Bellizzi A; Asselti M; Popescu O; Reshkin SJ; Paradiso A; Simone G
Oncol Rep; 2012 Sep; 28(3):889-94. PubMed ID: 22766563
[TBL] [Abstract][Full Text] [Related]
17. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract][Full Text] [Related]
19. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
[TBL] [Abstract][Full Text] [Related]
20. Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.
Schirosi L; Saponaro C; Giotta F; Popescu O; Pastena MI; Scarpi E; Mangia A
Transl Oncol; 2020 Feb; 13(2):186-192. PubMed ID: 31865181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]